BioCentury | Dec 17, 2001
Clinical News

EmdogainGel regulatory update

...Japan granted marketing approval for BIOR's EmdogainGel amelogenin tooth enamel matrix protein gel to treat periodontal...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

...fell SEK2.6 (15%) to SEK14.2 on the week after two European trials of its Emdogain amelogenin...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

...fell SEK2.6 (15%) to SEK14.2 on the week after two European trials of its Emdogain amelogenin...
BioCentury | Jun 18, 2001
Clinical News

Emdogain: Marketed to treat moderate to severe defects associated with periodontitis

...SSE:BIOR; BIORY), Malmo, Sweden Product: Emdogain Business: Dental Therapeutic category: Tissue replacement Target: NA Description: Amelogenin...
BioCentury | Jun 14, 2001
Clinical News

Emdogain clinical results

...Biora (SSE:BIOR; BIORY) said that in two European trials, its Emdogain amelogenin tooth enamel matrix protein...
BioCentury | Feb 12, 2001
Finance

Ebb & Flow

...week's jump of SEK7 to SEK 21.4 (49 percent) on FDA approval of the company's Emdogain gel...
BioCentury | Feb 5, 2001
Clinical News

Emdogain Gel regulatory update

...The FDA granted marketing approval for Emdogain amelogenin tooth enamel matrix protein gel formulation to treat...
...approved in 1999 (see BioCentury, Aug. 16, 1999). Biora AB (SSE:BIOR; BIORY), Malmo, Sweden Product: Emdogain Gel...
BioCentury | Jan 30, 2001
Company News

FDA approves Emdogain Gel

...The FDA granted marketing approval to Biora (BIORY; SSE:BIOR) for its Emdogain amelogenin tooth enamel matrix...
BioCentury | Jun 19, 2000
Company News

Biora sales and marketing update

...BIOR launched in Europe its Emdogain amelogenin tooth enamel matrix protein gel formulation to promote the...
BioCentury | Apr 3, 2000
Clinical News

Emdogain Gel regulatory update

...tissues and tooth reattachment after periodontal flap surgery. Biora AB (SSE:BIOR; BIORY), Malmo, Sweden Product: Emdogain Gel...
Items per page:
1 - 10 of 12